中医药调控NLRP3炎症小体治疗卒中后认知障碍的研究进展
DOI:
作者:
作者单位:

1.河南中医药大学 康复医学院;2.河南省中医院(河南中医药大学第二附属医院 康复科)

作者简介:

通讯作者:

中图分类号:

基金项目:

] 河南省自然基金(242300420111);河南中医药大学“双一流”创建工程(HSRP-DFCTCM-2023-3-11);河南省首批中医药拔尖人才培养对象(豫中医科教(2018)35号),2025年度河南省中医药科研专项联合共建课题(课题号:2025LHZX2010),河南省中医药科研专项课题(2025ZY3063)


Traditional Chinese Medicine Treats Post-Stroke Cognitive Impairment by Modulating NLRP3 Inflammasome:A Review
Author:
Affiliation:

1.Henan University of Chinese Medicine School of Rehabilitation Medicine;2.Henan Province Hospital of Traditional Chinese Medicine,Rehabilitation Department(The Second Affiliated Hospital of Henan University of Chinese Medicine,Rehabilitation Department)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    卒中后认知障碍(PSCI)是卒中后最常见并发症,以记忆力减退、执行功能障碍、注意力不集中为主要临床表现,严重影响患者生存质量,给社会及家庭带来沉重负担。神经炎症反应在PSCI的发生发展中扮演关键角色,NOD样受体蛋白3(NLRP3)炎症小体是调控神经炎症的核心分子靶点,通过介导神经炎症反应、破坏血脑屏障、诱导神经元凋亡、损伤突触功能等途径,参与PSCI的发生和发展。近年来大量研究证实,单味中药及活性成分、中药复方、针刺及艾灸等中医药疗法可通过调控NLRP3炎症小体及其相关信号通路,抑制神经炎症反应,保护神经功能,改善PSCI患者认知水平。该文系统梳理近5年相关文献,旨在综述中医药在调控NLRP3炎症小体治疗PSCI的研究进展,以期为中医药防治PSCI提供理论依据与实践参考。

    Abstract:

    Post-stroke cognitive impairment (PSCI) is the most common complication after stroke, characterized by memory loss, executive dysfunction and inattention as the main clinical manifestations. It seriously affects patients" quality of life and imposes a heavy burden on society and families. Neuroinflammation plays a crucial role in the occurrence and development of PSCI. NOD-like receptor protein 3 (NLRP3) inflammasome is a key molecular target for regulating neuroinflammation. It participates in the occurrence and progression of PSCI by mediating neuroinflammatory responses, disrupting the blood-brain barrier, inducing neuronal apoptosis, and impairing synaptic function. In recent years, numerous studies have confirmed that TCM therapies, such as single Chinese herbs and their active components, Chinese herbal compounds, and acupuncture and moxibustion, can inhibit neuroinflammation, protect neurological function, and improve cognitive levels in PSCI patients by regulating the NLRP3 inflammasome and its related signaling pathways. This paper systematically combs relevant literatures in the past 5 years, aiming to review the research progress of TCM in regulating the NLRP3 inflammasome for the treatment of PSCI, so as to provide a theoretical basis and practical reference for the prevention and treatment of PSCI with TCM.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2026-03-05
  • 最后修改日期:2026-06-03
  • 录用日期:2026-06-03
  • 在线发布日期:
  • 出版日期: